Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Post by Hopeforthebeston Jul 12, 2024 11:43am
82 Views
Post# 36130248

Re: Strategic acquisitions

Re: Strategic acquisitionsOf course gagnon would be on the lookout for new acquistions, like the one he did with Juvenite, took a company that had hundred of thousands in sales and ran that down to less than $30,000 in sales per year meanwhile appointing himself as CEO and paying himself at least $250,000 per year. 
That gagnon has a special kind of talent bankrupt anything he touches, devalue shareholder value, increase top heavy management, lie to shareholders (can we say OATS) and still he manages to pay him and his friends mega bucks
<< Previous
Bullboard Posts
Next >>